Harbour Investments, Inc. Horizon Therapeutics Public LTD CO Transaction History

Harbour Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $5,473 - $5,788	-51 Reduced 38.93%	80 $8,000
Q4 2022 Feb 15, 2023	SELL	$62.39 - $113.8 $32,505 - $59,289	-521 Reduced 79.91%	131 $14,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $11,274 - $16,523	142 Added 27.84%	652 $52,000
Q4 2021 Feb 16, 2022	SELL	$98.56 - $119.91 $25,724 - $31,296	-261 Reduced 33.85%	510 $55,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $1,011 - $1,214	11 Added 1.45%	771 $84,000
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $8,365 - $9,304	-97 Reduced 11.32%	760 $71,000
Q1 2021 Aug 17, 2021	BUY	$71.83 - $95.48 $61,558 - $81,826	857 New	857 $79,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.